Q32 Bio QTTB
NASDAQ QTTB
$8.80 +0.13 (+1.50%)
At close: Oct 22, 2026 · 4:00 PM EDT

Q32 Bio (QTTB) Restructuring Costs (2023)

Updated

Q32 Bio (QTTB) posted Restructuring Costs of $2.69 million for Q4 2023, down 59.5% from the prior quarter.

Analysis

Q32 Bio (QTTB) Restructuring Costs (2023) Analysis & Trends

For FY2023, Q32 Bio's Restructuring Costs came in at $9.33 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 Q32 Bio 208.88 Mn -65.41 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 2.69 Mn
Sep 30, 2023 6.64 Mn
API Access

Q32 Bio Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=QTTB&period=max&api_key=YOUR_API_KEY